INSM FY 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$136M+1287.6% YoY

Gross Profit

$112M82.3% margin

Operating Income

-$235M-172.4% margin

Net Income

-$254M-186.4% margin

EPS (Diluted)

$-3.01

Cash Flow

Operating Cash Flow

-$251M

Free Cash Flow

-$293M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$742M

Total Liabilities

$481M

Stockholders' Equity

$262M

Cash & Equivalents

$487M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$136M	$10M	+1287.6%
Gross Profit	$112M	$7M	+1414.5%
Operating Income	-$235M	-$307M	+23.5%
Net Income	-$254M	-$324M	+21.6%